NutriStack
Berberine and Metformin, a caution.
Both metformin and berberine lower blood glucose through overlapping mechanisms including AMPK activation. Combined use creates a significant risk of additive hypoglycemia. Berberine also inhibits CYP enzymes and may increase metformin plasma concentrations, further amplifying the hypoglycemic effect.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Pair type
- Caution
- Evidence (highest tier)
- Moderate
- Source citations
- 4 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Moderate evidence
Caution
What is happening. Both metformin and berberine lower blood glucose through overlapping mechanisms including AMPK activation. Combined use creates a significant risk of additive hypoglycemia. Berberine also inhibits CYP enzymes and may increase metformin plasma concentrations, further amplifying the hypoglycemic effect.
Mechanism. Both metformin and berberine activate AMP-activated protein kinase (AMPK), improve insulin sensitivity, and reduce hepatic glucose production. Berberine may also inhibit CYP2D6, CYP2C9, and CYP3A4, but this does NOT affect metformin (which is renally excreted unchanged, not CYP-metabolized). The additive AMPK activation creates significant hypoglycemia risk.
Recommendation. Avoid combining berberine with metformin without medical supervision. If used together, blood glucose must be monitored very closely, especially when initiating the combination. Dose reduction of one or both agents may be necessary.
Sources (4)
- Yin J et al. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717. PMID 18442638
- Zhang Y et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008;93(7):2559-2565. PMID 18397984
- Maruthur NM, Tseng E, Hutfless S, Wilson LM et al.. Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis. Annals of Internal Medicine. 2016. PMID 27088241
- Asbaghi O, Ghanbari N, Shekari M et al.. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials.. Clinical Nutrition ESPEN. 2020. PMID 32690176
Stack Score
How this pair moves the number.
Effect on the composite score
If both Berberine and Metformin are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.